Atlas Trials

The Effect of Tesetaxel on the QTc Interval and the Effect of Food, Itraconazole, and Rifampin on Tesetaxel Pharmacokinetics in Patients With Advanced Solid Tumors

Clinical trial NCT04312282 · TERMINATED

Trial details

NCT number
NCT04312282
Sponsor
Odonate Therapeutics, Inc.
Status
TERMINATED
Phase
Phase 1
Study type
INTERVENTIONAL
Advanced Solid Tumors
Start date
2020-03-06
Primary completion
2020-09-30
Enrollment
93

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.